H1N1 deaths increase as mutations combine - vaccine & antiviral resistant, lung hemorrhaging virus
The World Health Organization has reported that global deaths from the H1N1 virus have increased by 1000 in the past week.
At the same time, the H1N1 virus is mutating, with each mutation causing different effects in patients, and combining in some cases. The national medical laboratory in Britain reported that the H1N1 vaccine would probably not be effective against the variant of the swine flu virus found in the Ukraine flu outbreak. This variant,…causes bleeding in the lungs. Another H1N1 mutation results in the resistance to treatment with antiviral medication.
Swine flu vaccine won't prevent infection with deadly H1N1 mutated virus.
Lung hemorrhaging is being caused by a swine flu mutation that has been reported in China, Norway, France, and the Ukraine as having a receptor binding domain of D225G. In the United States, there has been a report of fatalities in patients with hemorrhaged lungs, but the mutation has not been confirmed.
Tamiflu-resistant H1N1 mutation
A strain of H1N1 that is resistant to Tamiflu, an antiviral medication, has been found worldwide. Clusters occurred in North Carolina and Wales.